|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 26, 2017 ) Asia-Pacific Companion Diagnostics Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 27.91% to reach USD 2.17 billion by 2021, from USD 0.63 billion in 2016, which amounts to a cumulative growth of USD 1.54 billion.
A companion diagnostics device is a medical device that provides information which is necessary for drug safety and effectives or any other biological product. This helps the patients to determine benefits derived from therapeutics products and risks and side effects involved with it.
To give a deeper idea about the market, companion diagnostic involves in-vitro diagnostic devices which help in enhancement of therapeutic treatment. These companion diagnostics have made systematic pharmacogenomic data in relation with drugs into the prescription labels so that it’s easier to assist and decide the most optimal treatment of the patient. . Internationally, most of the industrialized nations are spending a huge part of their GDP on healthcare necessities. The US is set to devote almost 20% of its GDP on healthcare by 2017, a higher proportion than any other developed country.
The report also presents detailed analysis of multitude of factors affecting the diagnostic imaging market bearing either positive or negative outcomes. Some of those factors are
• Increasing prevalence of cancer, cardiac, neurological, and musculoskeletal disorders,
• Rise in cognizance for prompt diagnosis,
• Rising number of diagnostic imaging techniques,
• Improving healthcare infrastructure in developing markets,
• Stringent Government Regulations,
• Rising awareness among public.
For Full Report refer to: http://www.marketdataforecast.com/market-reports/asia-pacific-companion-diagnostics-market-643/
For granular level understanding the Companion Diagnostics Market is segmented based on indication and technology, each being provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Indication the market is segmented as Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases. Based on Technology it is further segmented into Immunohistochemistry and molecular diagnostics (in-situ hybridization, real time PCR and gene sequencing).
India and China are the major economies which have unexplored customer base covered in the study. The report also focuses on other regions like Japan, Australia, South Korea and Rest of Asia-Pacific. China and India are fastest growing leading to faster growth of Asia-Pacific Companion Diagnostics Market.
Free Sample for report: http://www.marketdataforecast.com/market-reports/asia-pacific-companion-diagnostics-market-643/request-sample
Some of the key players that operate in the Asia-Pacific Companion Diagnostics market include Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc. and Qiagen Ltd. Due to technological advancements and increasing population demands there is an increase in the competition among key players.
Enquire about the report: http://www.marketdataforecast.com/market-reports/asia-pacific-companion-diagnostics-market-643/inquire
The Asia- Pacific Companion Diagnostics market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of indication, technology, along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Diagnostics Market:
Companion Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-companion-diagnostics-market-640/
In-vitro Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-in-vitro-diagnostics-market-146/
Preclinical In-vivo Imaging Market: http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/
Nuclear Medicine Diagnostics Market: <||>rnhttp://www.marketdataforecast.com/market-reports/global-nuclear-medicine-diagnostics-market-123/
Ultrasound Devices Market: http://www.marketdataforecast.com/market-reports/global-ultrasound-devices-market-575/
Buy now at: https://www.marketdataforecast.com/cart/buy-now/asia-pacific-companion-diagnostics-market-643
About us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
